NIH-funded research Career grant

Understanding how certain cells in the brain develop to help repair nerve damage in multiple sclerosis.

Official title: Transcriptional regulation of oligodendroglial differentiation

Funded at Stanford University · NIH-10984598 · Data updated 2026-11-12

This study is looking at how certain cells in the brain that help repair nerve coverings might not work properly in multiple sclerosis, with the hope of finding new ways to help improve myelin repair and support better nerve function for patients.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startAugust 1, 2024
Project endJune 30, 2026
Funding year2024
Award (this year)$125,685
NIH project number1K99NS135117-01A1
Project IDNIH-10984598 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with multiple sclerosis who are experiencing symptoms related to nerve damage.

Less likely to help

Patients with other neurological disorders unrelated to myelin damage may not receive benefits from this research.

What this research studies

This research investigates the mechanisms that control the differentiation of oligodendrocyte precursor cells (OPCs), which are crucial for producing myelin, the protective sheath around nerves. By exploring the role of transcription factors and circadian rhythms in OPC behavior, the study aims to uncover why remyelination fails in multiple sclerosis (MS). Patients may benefit from insights that could lead to new therapies aimed at enhancing myelin repair and improving neurological function. The research employs advanced techniques, including CRISPR-based screens, to analyze gene expression and cell behavior in the context of MS.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that enhance myelin repair in patients with multiple sclerosis, potentially improving their quality of life.

How similar studies have gone: Previous research has shown promising results in understanding the role of transcription factors in neural repair, suggesting that this approach could yield significant insights.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Rojo Capitanio, Daniela — Stanford University
  • Study coordinator: Rojo Capitanio, Daniela

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.